Table 2.
Characteristics of the antibiotic treatment
| n | % | ||
|---|---|---|---|
| Pacients on antibiotics (n; %) | 43 | 30.71% | |
| Atezolizumab | 12 | 27.90% | |
| Nivolumab | 12 | 27.90% | |
| Pembrolizumab | 19 | 44.18% | |
| Antibiotic type (n; %) | 51* | ||
| Fluoroquinolone | 24 | 47.06% | |
| Ciprofloxacin | 4 | ||
| Levofloxacin | 18 | ||
| Moxifloxacin | 2 | ||
| Beta-Lactam | 20 | 39.22% | |
| Penicillin | 13 | ||
| Cephalosporin | 7 | ||
| Aminoglycoside | Tobramycin | 1 | 1.96% |
| Glycopeptide | Vancomycin | 1 | 1.96% |
| Lincosamide | Clindamycin | 1 | 1.96% |
| Macrolide | Azithromycin | 3 | 5.88% |
| Others | Fosfomycin | 1 | 1.96% |
| Indication (n; %) | |||
| Respiratory infection | 41 | 80.39% | |
| Urinary tract infection | 4 | 7.84% | |
| Bacteriemia | 2 | 3.92% | |
| Others | 4 | 7.84% | |
| Duration | |||
| Mean - range (days) | 8,25 | 1-15 |